The Role of Push Enteroscopy in Patients With Passing Melena With Nondiagnostic EGD.
The Diagnostic Yield of Push Enteroscopy in Patients With Passing Melena Without Hematemesis, With Nondiagnostic EGD : A Multicenter Study
1 other identifier
interventional
77
1 country
1
Brief Summary
Melena is often caused by upper gastrointestinal (GI) bleeding; therefore, esophagogastroduodenoscopy (EGD) is the first preferred diagnostic tool. However, EGD fails to identify the bleeding source in about 25% of cases. Guidelines recommend colonoscopy for the subsequent investigation. However, the diagnostic yield of colonoscopy is reportedly low, varying from 4.76% to 35%. Even when EGD and colonoscopy have been performed, 4% to 15% of bleeding cases remain unexplained, suggesting small bowel origins. While video capsule endoscopy (VCE) is recommended due to its high diagnostic yield and noninvasive nature, its limitations include missing proximal small bowel lesions due to rapid transit and the inability to perform therapeutic interventions. Push enteroscopy (PE) is a straightforward, cost-effective technique with a reported 30% to 50% diagnostic success rate for such obscure GI bleeding. This study aims to evaluate the diagnostic yield of PE compared to colonoscopy in patients presenting with melena, no hematemesis, and negative EGD results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFirst Submitted
Initial submission to the registry
August 25, 2024
CompletedFirst Posted
Study publicly available on registry
August 28, 2024
CompletedAugust 29, 2024
August 1, 2024
3.3 years
August 25, 2024
August 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Yield of Push Enteroscopy
This study aimed to evaluate the diagnostic yield of push enteroscopy in patients presenting with melena, without hematemesis, and with a negative EGD.
30 day
Secondary Outcomes (1)
Diagnostic Yield of Colonoscopy
30 day
Study Arms (1)
Patients with Melena, No Hematemesis, and Nondiagnostic EGD
EXPERIMENTALConsecutive patients who presented with melena (defined as black, tarry stools) without hematemesis, in whom EGD did not identify a bleeding source, were included for further investigation
Interventions
All patients enrolled in this study underwent evaluation using push enteroscopy (PE)
After push enteroscopy (PE), all patients subsequently underwent a colonoscopy on the same day or the next day. However, if a culprit lesion was identified during PE and the patient was considered at risk for undergoing colonoscopy, the colonoscopy was not performed and was presumed to be negative.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years or older.
- Patients admitted to the hospital for acute gastrointestinal bleeding, presenting with symptoms of melena.
- Patients who have undergone esophagogastroduodenoscopy (EGD) without identification of the source of gastrointestinal bleeding.
- Patients who have signed informed consent to participate in the study.
You may not qualify if:
- Patients with symptoms of hematemesis, coffee ground emesis, or detection of blood via a gastric lavage tube.
- Patients with unstable vital signs before undergoing push enteroscopy.
- Patients with conditions that contraindicate endoscopy, such as severe asthma or serious cardiac conditions.
- Patients with a history of bleeding disorders or uncorrectable coagulation abnormalities.
- Patients who have contraindications to bowel preparation with polyethylene glycol.
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mahidol Universitylead
- Siriraj Hospitalcollaborator
Study Sites (1)
Gastroenterology division, Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, 10700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 25, 2024
First Posted
August 28, 2024
Study Start
July 8, 2019
Primary Completion
October 30, 2022
Study Completion
December 30, 2022
Last Updated
August 29, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Other researchers can contact us anytime.
- Access Criteria
- We will provide our protocol and/or data upon request.
We are willing to provide our data to researchers who require it. For example, those who want to do systematic review and meta-analysis.